Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

CGCT vs LION: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

LION Wins Head-to-Head Institutional Verdict (3–1 across 6 Pillars · 5–1 Matrix Metrics)

LION Overall Winner 6-Pillar Tally: CGCT 1 – 3 LION (2 Tie) Matrix Metrics: CGCT 1 – 5 LION

As of Nov 16, 2026, Lionsgate Studios Corp. (LION) is the stronger overall head-to-head candidate over CGCT (CGCT) in the Tradestie Institutional Equity Comparison Engine, winning 5–1 core matrix metrics and 3–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). CGCT carries a Unified Composite Score of 65.0/100 (BUY) at $11.90 (N/M Forward P/E, 0.0% operating margin), whereas LION carries 34.0/100 (SELL) at $14.03 (62.6x Forward P/E, 0.0% operating margin).

  • Composite vs. Pillar Nuance: While CGCT currently prints a higher short-term Unified Composite Score (65.0/100 BUY vs. LION 34.0/100 SELL), LION captures the overall institutional head-to-head verdict (5–1 matrix metrics and 3–1 across the 6 pillars) due to superior fundamental profitability (0.0% vs. 0.0% operating margin) and revenue trajectory (+0.0% vs. +0.0% YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CGCT vs LION
CGCT US Equity
CGCT
Institutional Equity
$11.90
-2.14% 1D
Market Cap $509.6M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.17β · 85% Vol
Unified Composite Score
65.0 / 100 BUY
Tech 75.0 Fund 62.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (3.6% over 20 days), RSI 58
RSI-14: 57.7 · SMA20: $11.19 · SMA50: $10.66
LION NYSE Head-to-Head Winner
Lionsgate Studios Corp.
Services-Motion Picture & Video Tape Production
$14.03
+0.0% 1D
Market Cap $4.1B
TTM Revenue N/A
Forward P/E 62.6x
Beta / 30D Vol 0.92β · 74% Vol
Unified Composite Score
34.0 / 100 SELL
Tech 50.0 Fund 33.0 Flow 60.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (5.3% over 20 days), RSI 65
RSI-14: 64.9 · SMA20: $13.06 · SMA50: $11.91

6-Pillar Scorecard Institutional Category Breakdown (CGCT 1 – 3 LION)

Columns: Metric · CGCT · LION
1. Valuation Multiples LION
Forward P/E N/M 62.6x
Trailing P/E 41.0x 34.8x
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale LION
Revenue Growth (YoY) +0.0% +0.0%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) N/A N/A
Market Cap $509.6M $4.1B
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin 0.0% 0.0%
Net Profit Margin 0.0% 0.0%
Return on Equity (ROE) 0.0% 0.0%
4. Balance Sheet & Cash Flow CGCT
Cash Generation (TTM) N/A $148M
Cash Flow Margin N/A N/A
Net Cash / Leverage 0.0% ROE $3.63B Net Debt
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning LION
Options Structure Phase UNCLASSIFIED CONSOLIDATION
Current IV / %ile N/A (N/A) 57.5% (10th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markup ACCUMULATION · Markup
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Shell Companies Operator Shell Companies Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CGCT (1) vs LION (5)
Institutional Metric CGCT LION Criterion Row Edge
Market Capitalization
Scale
$509.6M $4.1B Larger Scale LION
Trailing P/E Ratio
Valuation
41.0x 34.8x Lower Multiple LION
Forward P/E Ratio
Valuation
N/M 62.6x Lower Multiple LION
Revenue Growth (YoY)
Growth
+0.0% +0.0% Higher Growth Tie
Operating Margin (TTM)
Profitability
0.0% 0.0% Higher Margin Tie
Net Profit Margin
Profitability
0.0% 0.0% Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
0.0% 0.0% Higher ROE Tie
52-Week Range Position
Momentum
44% ($9–$15) 74% ($6–$17) Stronger Trend LION
Beta / 30D Volatility
Risk Regime
0.17β · 85% Vol 0.92β · 74% Vol Lower Realized Risk LION
Unified Institutional Score
Composite Signal
65.0 / 100 (BUY) 34.0 / 100 (SELL) Higher Composite CGCT
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (0.0% ROE) $148M ($3.63B Net Debt) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CGCT +9.29 pp
CGCT: +14.31% · LION: +5.02%
3M Horizon LION +9.83 pp
CGCT: +15.87% · LION: +25.7%
6M Horizon LION +84.57 pp
CGCT: +17.24% · LION: +101.81%
1Y Horizon LION +84.57 pp
CGCT: +17.24% · LION: +101.81%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CGCT vs LION. Trailing 12-month operating profitability (CGCT 0.0% vs LION 0.0%) and valuation multiples (CGCT N/M vs LION 62.6x Forward P/E) are benchmarked directly in Pillar 4 below.

CGCT ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E0.0% · N/M
LION ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E0.0% · 62.6x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CGCT UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CGCT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LION CONSOLIDATION
106d in phase · OBV ACCUMULATION
Current IV 57.5%
IV Percentile 10th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact LION Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CGCT Moat Profile Cyclical / Execution-Driven Positioning
Shell Companies Operator
Competes within the Shell Companies value chain with $509.6M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
LION Moat Profile Cyclical / Execution-Driven Positioning
Shell Companies Operator
Competes within the Shell Companies value chain with $4.1B market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ CGCT vs LION Key Questions & Quantitative Answers

As of Nov 16, 2026, Lionsgate Studios Corp. (LION) is the stronger overall head-to-head candidate over CGCT (CGCT) in the Tradestie Institutional Equity Comparison Engine, winning 5–1 core matrix metrics and 3–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Options & Positioning). CGCT carries a Unified Composite Score of 65.0/100 (BUY) at $11.90 (N/M Forward P/E, 0.0% operating margin), whereas LION carries 34.0/100 (SELL) at $14.03 (62.6x Forward P/E, 0.0% operating margin). Composite vs. Pillar Nuance: While CGCT currently prints a higher short-term Unified Composite Score (65.0/100 BUY vs. LION 34.0/100 SELL), LION captures the overall institutional head-to-head verdict (5–1 matrix metrics and 3–1 across the 6 pillars) due to superior fundamental profitability (0.0% vs. 0.0% operating margin) and revenue trajectory (+0.0% vs. +0.0% YoY).

LION leads the Growth & Scale pillar: CGCT posts +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with LION at +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, CGCT generates N/A in USD-normalized revenue versus N/A for LION. In operating R&D and SG&A reinvestment, CGCT deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for LION.

LION screens cheaper on headline valuation multiples. CGCT trades at N/M Forward P/E, 41.0x Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas LION trades at 62.6x Forward P/E, 34.8x Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CGCT (0.0% ROE) versus LION (0.0% ROE) capital efficiency.

In options market volatility and institutional positioning, CGCT carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.17β · 85% Vol realized risk). By comparison, LION carries 57.5% implied volatility (10th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.92β · 74% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.